The early emergence of macrophages and their large pattern of tissue distribution during development suggest that they may play a critical role in initial steps of embryogenesis. Here, we show that monocytic cells derived from human ES cells (hESC) and fetal liver follow a differentiation pathway different to that of adult cells, leading to specific functions. Embryonic and fetal monocytic cells differentiated from a CD14l ow CD16precursor to form CD14 high CD16 + cells without producing the CD14 high CD16cell population that predominates in adult peripheral blood. Both demonstrated an enhanced expression of genes encoding tissue degrading enzymes, chemokines and scavenger receptors, previously reported for M2 macrophages. In comparison to adult blood monocytes, they secreted high amounts of proteins acting on tissue remodeling and angiogenesis and most of them expressed the Tie2 receptor. Furthermore, they promoted the vascular remodeling in xenotransplanted human tumors.
INTRODUCTION
The mononuclear phagocyte system (MPS) is a network of highly versatile and multifunctional cells that include peripheral blood monocytes, dendritic cells and tissue macrophages and plays major roles in development, scavenging, inflammation and antipathogen defenses [1] [2] [3] . These cells originate from hematopoietic stem cells in the bone marrow through differentiation steps generating common myeloid progenitors shared with neutrophils, then enter the blood as monocytes to be recruited into normal healthy tissues or at sites of injury where they differentiate into dendritic cells or macrophages 1, 4 .
Macrophages demonstrate a remarkable heterogeneity related to their phenotype, localization and function 1, 3, 5 .
It was proposed to distinguish M1 macrophages attributed with pro-inflammatory functions and M2 macrophages attributed with wound healing or tissue remodeling functions, which is an over-simplistic but useful categorization of this complex cell lineage [6] [7] . It remains unsolved whether these heterogeneous functions are determined only by the local tissue environment or reflect also specific developmental maturation pathways 5, [8] [9] .
In mice and birds, macrophages are part of primitive hematopoiesis and first emerge in the yolk sac at day 7.5 post-coïtum (dpc). A second wave of macrophages is formed in the yolk sac between 8-8.5 dpc through maturation of a myeloid-erythroid progenitor. These macrophages resemble those appearing later from the differentiation of a lympho-myeloid hematopoietic stem cell present in the fetal liver [10] [11] . Macrophages generated in the fetal liver are rapidly dispersed in all embryonic tissues 12 
. The early
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From emergence of macrophages and their large pattern of tissue expression during development suggest a critical role of these cells in initial steps of embryogenesis 13, 14 .
As in adult mice, macrophages play a key role in innate response to pathogens and constitute the primary host defense in the mouse embryo. Several lines of evidence suggest also trophic roles for mouse embryonic macrophages, including bone morphogenesis, ductal branching, neuronal networking and angiogenesis [14] [15] . Gene signature of mouse embryonic macrophages is shared with a subset of adult peripheral blood monocytes expressing the angiopoietin receptor Tie2, known as TEMs, which may be part of Gr1 -/Ly-6c lo /CX3CR1 high /CCR2 -/CD62Lcells [16] [17] . Their human counterparts belong to the less frequent subpopulation of 'non classical" circulating monocytes with a CD14 + CD16 + phenotype 3, [18] [19] . Part of the embryonic mouse macrophage signature is shared also with the so-called tumor-associated macrophages (TAM) that have tumor remodeling and immunosuppressive functions 13, 17, [20] [21] . Collectively, these data suggest that embryonic mouse macrophages are specialized in tissue remodeling and that similar cells are recruited or reprogrammed during tumor development 14 . Common remodeling and immunosuppressive functions of M2-polarized macrophages may link normal developmental and pathological processes.
Our knowledge on the development and functional properties of human MPS during ontogeny is much lower, due to the limited availability of human embryos at the earliest stages of development 22 . In recent years, human embryonic stem cells (hESC) have been used as an in vitro model of the early stages of tissue maturation. In vitro hESC hematopoietic differentiation recapitulates the main stages of early in vivo embryogenesis [23] [24] [25] [26] [27] . This suitable model was used here for studying embryonic monopoiesis. More specifically, we examined monocytes/macrophages obtained from For personal use only. on September 24, 2017. by guest www.bloodjournal.org From 6 differentiation of hESC and fetal liver CD34 + cells issued from first trimester fetuses. We show that, in early stages of human development, most of the generated fetal and embryonic monocytic cells share a specific pathway of differentiation which correlated with transcriptional and functional patterns that characterize anti-inflammatory and tissue remodeling cells. (BMP-4, 10 ng/ml), vascular endothelial growth factor (VEGF, 5 ng/ml), interleukin-3 (IL-3, 100 U/ml), fetal liver tyrosine kinase 3 ligand (FLT3-ligand, 10 ng/ml) (all from Peprotech, Neuilly-sur-Seine,France), stem cell factor (SCF, 50 ng/ml) (a gift from Amgen, Thousand Oaks, CA) and thrombopoietin (TPO, 10 ng/ml) (a gift from Kirin laboratories, Tokyo, Japan). CD14 + cells were sorted and their terminal differentiation towards the monocyte/macrophage lineage was achieved in presence of monocyte-colony stimulating factor (M-CSF, 50 ng/ml), granulocyte-macrophage CSF (GM-CSF, 20 ng/ml), IL-3 (100 U/ml) and FLT3-L (10 ng/ml) (Peprotech). Cultures were maintained in a 5% CO2/5% O2 environment and differentiation medium was changed every four days.
Generation of monocyte/macrophage from fetal and adult CD34 + cells
Adult CD34 + cells were recovered from cytapheresis performed in healthy donors submitted to hematopoietic stem cell (HSC) harvest. Fetal CD34 + cells were recovered For personal use only. on September 24, 2017. by guest www.bloodjournal.org From from fetal liver ranging from 10-17 weeks estimated gestational age (EGA), obtained after legal abortion. CD34 + cells from fetal liver or from adult peripheral blood mononuclear cells (PBMCs) were purified using CD34 immunomagnetic beads (MACS;
Miltenyi Biotec). Proliferation and differentiation of CD34 + cells towards the monocyte/macrophage lineage was achieved in conditions similar to those described for hESC, in the presence of M-CSF, GM-CSF, IL-3, and FLT3-L.
Human peripheral blood monocyte sorting
PBMCs were sorted from cytaphereses performed in healthy donors. PBMCs were isolated using a Ficoll gradient and monocytes were enriched by adherence in IMDM supplemented with 15% FBS.
Flow cytometry and cell sorting
To obtain a single-cell suspension, EB cultures were treated with trypsin-EDTA (0.25%) (Sigma-Aldrich, St. Louis) for 5 min at 37°C. Adherent monocytes from hESC, fetal liver and blood CD34 + cells, or peripheral blood were detached from the plastic plates by incubation with cold EDTA/PBS (2 mM) for 10 min. Single-cell suspension was incubated for 30 min at 4°C with the different conjugated monoclonal antibodies (MoAbs) and washed twice. Flow cytometric characterization was performed using a panel of anti-human MoAbs : phycoerythrin (PE)-conjugated anti-CD14, CD16, CD163, CD64, CCR5, CD34 (Becton Dickinson) and Tie2 (R&D); (FITC)-conjugated anti-CD16, CD15 (Becton Dickinson) and APC-conjugated anti-CD14, CD32, CD15, CD36, CD62L (Becton Dickinson), CD115 (R&D) and CD16 (Caltag). Cells were analyzed with a FacSort flow cytometer (Becton Dickinson, San Jose, CA). The percentage of positive For personal use only. on September 24, 2017. by guest www.bloodjournal.org From cells was determined as compared with isotypic controls establishing the background level of non-specific staining. CellQuest software (Becton Dickinson) was used for data acquisition and analysis. CD14 + or CD14 + CD16and CD14 + CD16 + cells were sorted after labeling with PE-conjugated anti-CD14 and APC-conjugated anti-CD16 MoAbs using a FacsDiva cell sorter (Becton Dickinson).
Cell morphology
CD14 + cells obtained from hESC were sorted after 21 days of differentiation from EB cultures and then cultured in the presence of FLT3-L, IL-3, GM-CSF and M-CSF.
Differentiated cells were stained with May-Grünwald-Giemsa solution, myeloperoxidase (MPO) and double-specific (naphthol AS-D chloroacetate esterase/non-specific-naphthyl butyrate esterase) esterase (Sigma Aldrich) in accordance with manufacturer's protocols.
Quantification of hematopoietic progenitors in semi-solid cultures
To study hematopoietic progenitors, dissociated cells from EB were plated in triplicate at a density of 3x10 4 cells/mL in human methycellulose medium H4434 containing cytokines (Stem Cell Technologies, Vancouver, BC, Canada). Progenitor-derived hematopoietic colonies were scored after 9 to 14 days. 
Total RNA isolation, RT-PCR and quantitative RT-PCR

In vivo tumor angiogenesis assays
All animal treatment and procedures were approved by the Institut Gustave Roussy animal care and use committee. Sorted CD14 + CD16 + from hESC, fetal CD34 + cultures and adult peripheral blood cells (2.5x10 5 ) were co-injected subcutaneously with U87 human glioma cells (5x10 6 ) in nude mice; control mice received only glioma cells (n=6, for each group). Tumors were grown for 5-7 days. To quantify angiogenesis, serial sections spanning the whole tumor were immunostained for CD34 (anti-mouse CD34, HyCult biotechnology, Uden, the Netherlands), followed by incubation with a rabbit antibody (Southern Biotech., Birmingham, AL) for 1 hour. Quantification of CD34stained micro-vessels was achieved using PIXCIT, a software package designed by the Groupe Régional d'Etudes sur le Cancer (Caen, France). Cell quantification was also performed using flow cytometry analysis with a (PE)-conjugated anti-human CD45
MoAb and a (FITC)-conjugated anti-mouse CD34 MoAb (n=6, for each group).
Phagocytosis assay
Cells (250,000) were suspended in 0.5 ml HBSS containing 10 uM luminol, incubated at 37°C in a thermostatic luminometer and stimulated (or not) with opsonized zymosan (0.5 mg/ml)(Sigma Aldrich, St.Louis). Changes in chemiluminescence were measured over a 30 min period.
Statistical analysis.
Differences in qPCR and protein analysis and in tumor angiogenesis assays between groups were assessed by pairwise t tests (Software, Inc.). The pool SD switch calculated a common SD for all groups and used that for all comparisons. The reported p value is a result of Bonferroni adjustment method. A P value < 5% was considered statistically significant.
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RESULTS
Embryonic monocytes and macrophages develop from hESCs through a process similar to bone marrow monopoiesis.
We induced human ESC differentiation into the monocyte/macrophage lineage through a 3 steps protocol ( Fig 1A) that included: step 1) embryoid body (EB) formation by culturing SSEA4 + H9 cell line ( Fig 1B) in low-attachment plates in the presence of BMP4 and VEGFA for 5 days; this led to mesoderm specification attested by the appearance of CD34 + VEGFR2 + cells ( Fig 1B) ; step 2) hematopoietic differentiation in the presence of SCF, FLT3-L, TPO and IL-3 from day 5 to day 21, which resulted in the emergence of CD34 + CD43 + cells ( Fig 1B) , a population of embryonic hematopoietic progenitors. Hematopoietic cells were detected in EB and floating cells emerging from EB and included cells expressing monocytic lineage markers, CD45, CD14 ( Fig 1B) and CD115 (M-CSFR, shown subsequently) as early as day 14; step 3) expansion and differentiation of the monocyte/macrophage lineage by sorting CD14 + cells between day 14 and day 21, then culturing these cells in the presence of M-CSF, GM-CSF, FLT3-L and IL-3, which efficiently supported the development of adherent cells with typical macrophage morphology ( Fig 1A, B ).
Using a methylcellulose-based colony-forming assay, we detected the emergence, at day 8, of primitive erythroid colonies comprising 6-20 cells (Ery-P) and primitive macrophage colonies (Macro-P) similar to those described in mouse hematopoiesis and To dissect more accurately the maturation of embryonic monocytes and macrophages, CD14 + cells from step 2 were sorted, cultured, harvested at different times and stained with May-Grunwald Giemsa. After one week in culture, we observed a large spectrum of cells belonging to the monocyte/macrophage lineage ( Fig 1D) , ranging from monoblasts Fig 1B) . Altogether, this experimental approach enabled the efficient generation of hESC-derived monocytes and macrophages (subsequently named monocytic cells) through the main stages of adult monopoiesis.
CD16 expression identifies two populations of CD14 + hESC-derived cells.
CD14 and CD16 (FcγR-III) are used to distinguish 2 subsets of monocytes with distinct functional properties in human adult peripheral blood. 1, 3, 28 The major subset called classical monocytes expresses CD14 but lacks CD16 (CD14 high CD16 -) whereas a minor subset that expresses CD16 includes at least two populations with distinct functions, CD14 high CD16 + and CD14 low CD16 + cells 29 . Macrophages usually express both CD14 and CD16, whatever their function 30 . Analysis of CD14 and CD16 expression at the surface of hESC-derived cells identified a major population of CD14 high CD16 + cells and a minor population of CD14 low CD16cells (Fig 2A, top panel) . These two subsets demonstrated distinct size and granularity, with CD14 high CD16 + cells showing scatter properties similar to those of macrophages (Fig 2A, top panel) . This pattern of CD14 and CD16 expression was quite different from that reported for adult monocytes and macrophages. To determine whether this differential pattern was related to the ontogenic stage or to the experimental procedure, we cultured fetal liver and adult peripheral blood CD34 + cells according to the step 3 of the culture protocol used for hESC. Culture of fetal liver CD34 + cells for 10 days in the presence of M-CSF, GM-CSF, IL-3 and FLT3-L generated the same pattern of CD14 and CD16 expression than hESC-derived cells ( (Fig 2A, bottom panel) , including a majority of CD14 high CD16cells with low scatter properties, similar to peripheral blood classical monocytes. These results suggested that mononuclear phagocytes generated in embryo and fetus might differ from those generated in adults.
We then sorted CD14 low CD16cells and cultured these cells in the presence of IL-3 or GM-CSF or M-CSF. CD14 low CD16cells derived from hESC and fetal liver CD34 + cells rapidly formed groups of 4-10 round proliferating cells that became larger clusters (10-50 cells) and semi-adherent colonies (more than 50 cells) after 7-10 days of culture ( Supplemental Fig 2A) . At day 9, cells with morphological characteristics of macrophages and a unique CD14 high CD16 + phenotype were observed, whatever the cytokine conditions ( Fig 2B, top and middle panel) . In contrast, sorted CD14 low CD16cells derived from adult CD34 + cells gave rise to CD14 high CD16cells that subsequently differentiated towards CD14 high CD16 + cells ( Fig 2B, bottom panel) . We subsequently focused on the phenotypic, molecular and functional characterization of the embryonic and fetal CD14 high CD16 + subset.
hESC-and fetal liver-derived monocytic cells demonstrate a phenotype of nonclassical monocyte.
Additional immunophenotyping of the embryonic and fetal CD14 high CD16 + subset revealed the expression of the scavenger receptors CD36 and CD163, Fc receptors CD32 (FcγRII) and CD64 (FcγRI). These cells also expressed CD15, CD33 and the cytokine receptors CD115 (M-CSFR) and CD116 (GM-CSFR). The majority of the cells expressed CCR5 and CX3CR1, but only marginal amounts of CD62L (L-selectin) and CCR2 (Fig 3, top panel) . Monocytic cells generated from adult CD34 + cells in the same conditions expressed more CCR2 and CCR5 and less CX3CR1 as compared to embryonic and fetal CD14 high CD16 + (Fig 3, bottom panel) . Expression of CX3CR1, CD115 and CD135 (FLT3) has been also described at the surface of the mouse macrophage-dendritic precursor 31 ; we confirmed that hESC-and fetal liver-derived monocytic cells gave rise to dendritic cells after 8-10 days in the presence of GM-CSF and IL-4 ( Supplemental Fig 2 B , C). These results enforced the previous suggestion that embryonic and fetal monocytic cells were developmentally close and distinct from adult cells. We thus determined the functional state of this population and this was performed in reference with the subset of peripheral blood monocytes expressing the same CD14 + 16 + phenotype.
Cytokine expression in hESC-and fetal liver-derived monocytic cells evokes antiinflammatory cells.
Cytokine production is the hallmark of the M1 versus M2 polarization paradigm in macrophages. hESC-and fetal liver-derived CD14 high CD16 + cells demonstrated a similar pattern of immune and anti-inflammatory cytokine mRNA expression (Supplementary Table 1 ). In both cases, IL-10 mRNA expression was higher than IL12α and IL12β mRNA, which suggested a M2 anti-inflammatory state ( Fig 4A) . These data were confirmed at the level of secreted proteins ( Fig 4B) . In contrast, CD14 + CD16 + adult monocytes demonstrated a similar production of IL-10 and IL-12. Treatment of hESC and fetal-derived monocytic cells with IFNγ and LPS stimulated the production of proinflammatory cytokines. This production remained ~10-fold lower than their adult counterpart with a significant differences in Il-12, Il-6 and TNFα secretion (p<0.05) ( Fig   4C) . Overall, levels of secreted cytokines in embryonic and fetal monocytic cells remained low when compared to adult CD14 + CD16 + monocytes, except for TGFβ1 whose level was respectively 7-and 2.5-fold increased in the supernatants of embryonic and fetal cells ( Fig 4D) . These results suggested that hESC and fetal liver-derived monocytic cells might have anti-inflammatory and immunosuppressive properties as well as tissue remodeling activity.
Monocytic cells derived from hESC and fetal liver have a gene signature of tissue remodeling activity.
We used qRT-PCR to compare the expression of 48 genes whose product is involved in tissue remodeling, angiogenesis, immune response, scavenging and chemotaxis in CD14 + CD16 + cells derived from hESC, those derived from fetal liver CD34 + cells or those isolated from adult peripheral blood. The expression of these genes was similar in hESC and fetal liver-derived monocytic cells in comparison with adult CD14 + CD16 + peripheral blood monocytes ( Fig 5A) . By pair-wise comparisons using t test, we observed a significant increase in the expression of genes encoding chemokines (CCL22, CCL17, CCL13; P = 0.01) related to a M2 polarization state and a decrease in the expression of the gene encoding the Th1 chemokine CXCL9 (P = 0.05) in hESC or fetal liver-derived cells compared to sorted adult cells (Fig 5 A, B) . hESC-and fetal liver-derived cells exhibited several fold up-regulation of genes encoding tissue degrading enzymes such as metalloelastases and metalloproteases, including MMP2, MMP12 and MMP1 (p = 0.01) and MMP7 and MMP9,in comparison to adult monocytes (Fig 5 A, B) . hESC-and fetal liver-derived cells also expressed high levels of scavenger receptor encoding genes MSR1 (macrophage scavenger receptor 1) and STABILIN-1, while the class A scavenger receptor gene SCARA5 was not detected. Compared to adult subset, they expressed high levels of the phagocytic mannose receptor gene MRC1, MARCO or the hyaluronan receptor-1 gene LYVE-1 that are characteristic markers of M2 macrophages (supplementary data, Table S2 ). This transcriptional pattern indicated that hESC and fetal liver-derived monocytic cells have characteristic of M2 polarized macrophages known to exert a wide range of homeostatic functions.
Monocytic cells derived from hESC and fetal liver express tissue remodelling proteins.
We used a protein array to explore the expression of 55 proteins involved in angiogenesis, vascular morphogenesis and tissue remodeling in hESC-and fetal liver-derived monocytic cells compared to sorted adult CD14 + CD16 + cells. Embryonic macrophages extensively secreted proteins acting on extracellular matrix and tissue remodeling such as TIMP-1, MMP-8, and Serpins ( Fig 6A) . Analysis of secreted protein using the Luminex technology corroborated these data and identified an impressive secretion of MMP-12 several folds higher than in adult cultures, in agreement with transcriptional studies (P = 0.04) ( Fig 6B) . Surprisingly, the secretion pattern of the fetal subset was closer to adult than embryonic macrophages ( Fig 6A and Supplementary data; table S3). Proteins acting specifically on angiogenesis, including VEGF, angiopoietin, thrombospondin (TSP), urokinase plasminigen activator (uPA) and pentraxin 3, were secreted at a lower level ( Fig 6B) , but embryonic macrophages still secreted a larger amount of angiogenic proteins when compared to adult blood CD14 low CD16 + monocytes that include ~70% of Tie-2-expressing monocytes (TEMs) known for their proangiogenic activity 19 . Proteins significantly increased in hES-derived cells in comparison to fetal and adult cells are indicated in Fig 6B. We confirmed that the specific profile of embryonic and fetal monocytic cells was not related to culture conditions by comparison with adult CD34 + cells derived-monocytic cell, obtained in the same culture conditions (n=3) (Supplementary data, Fig S3) .
Embryonic and fetal CD14 high CD16 + cells demonstrated phagocytic functions that can contribute to their remodeling activity. They showed ability to ingest apoptotic cells, including embryonic erythrocytes and granulocytes (Supplemental Fig 4A, top left panel) and Escherichia coli at 37 °C (Supplemental Fig 4A, Fig 4B) .
Monocytes/macrophages derived from hESC and fetal liver promote tissue remodeling
Tie-2 angiopoietin receptor is expressed on a subset of CD14 + CD16 + adult peripheral blood monocytes and Tie-2 expressing cells are required for the vascularization and growth of several tumor models 19 . Tie-2 was detected at the surface of ~70% of embryonic and virtually all fetal monocytes/macrophages ( Fig 7A) . Sorted hESC-and fetal liver-derived CD14 high CD16 + cells were co-injected subcutaneously with human U87 glioma cells in nude mice, a xenogenic model used for the demonstration of the proangiogenic effect of adult TEMs. U87 cells alone or co-injected with adult CD14 + CD16 + monocytes were used as controls. Developing CD34 + blood vessels were studied in tumors by immunochemistry at day 5-7. Computer-assisted image analysis showed that the overall vascular area was not significantly greater in tumors produced by co-injection of U 87 cells with embryonic or fetal macrophages than in controls ( Fig 7B) .
However, despite the early times of tumor growth (5-7 days), we observed a profuse vascular framework both in control and co-injected tumors (Supplemental Fig 4) . In an independent set of experiments, we observed, using cytometric analysis, that embryonic, fetal and adult cells were still present in the tumors on days of analysis, but at a significant larger extent for adult CD14 + CD16 + monocytes (p<0.05) ( Fig 7C) . Additional detailed morphological analysis showed that embryonic and fetal/macrophages promoted the development of large blood vessels with wide lumens, whereas CD14 + CD16 + adult For personal use only. on September 24, 2017. by guest www.bloodjournal.org From monocytes induced a framework of small capillaries ( Fig 7D) . Thus, embryonic and fetal monocytes/macrophages promote vascular morphogenesis and tissue remodeling.
The specific pattern of CD14 and CD16 expression, inflammatory cytokines and remodelling proteins was confirmed from monocytic cells issued from the H1 ES cell line (WiCell Research Institute; Madison, WI). (Supplementary data, Fig S5 ) For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
DISCUSSION
Ontogeny of monocyte/macrophage development has been investigated mainly in mice 10, 12, 14, 32 . In contrast, the establishment of MPS in human remains poorly understood.
The present study used hESC and fetal liver cell differentiation models to gain insights in the ontogeny of monocyte/macrophage in human. Using these two independent experimental approaches, we demonstrate that both hESC-and fetal liver-derived monocytes/macrophages arise through a similar developmental process and are specialized for specific homeostatic functions.
Monocytes/macrophages have been previously derived from hESCs by two approaches. One used hESC differentiation into hematopoietic cells on OP9 cells and led
to the identification of a GM progenitor that differentiated into monocytes/macrophages 33 . The second one used EB formation followed by monocyte/macrophage differentiation in the presence of M-CSF and IL-3 34 . Here, we set up a stepwise culture method with defined combinations of cytokines, which allowed to generate functional mature monocytes and macrophages. Of interest, we identified two sequential waves of embryonic monopoiesis temporally linked with the emergence of primitive and definitive erythroid colonies suggesting that this experimental protocol reproduces the main stages of embryonic hematopoiesis. Clonogenic assays and cytologic examination confirmed the emergence of monocytes/macrophages from hESC through steps that included the sequential formation of mixed progenitors, monocyte precursors, mature monocytes and macrophages as described for bone marrow monopoiesis. To monitor this differentiation in details, we combined CD14 and CD16 markers, which discriminate the 2 major types of monocytes, CD14 + CD16and CD14 + CD16 + monocytes, in adult peripheral blood 29 .
These cells have been shown to exhibit distinct phenotypes and functions although the CD14 + CD16 + cell population seems quite heterogeneous. In addition, CD16 expression appears at the surface of CD14 + CD16adult peripheral blood monocytes when induced to differentiate into macrophages upon M-CSF exposure (personal results). In hESC and fetal liver-derived cultures, these two markers identified 2 populations either CD14 low CD16or CD14 high CD16 + . The first population clearly consisted of precursors capable to proliferate and to give rise to the second population in the presence of M-CSF, GM-CSF, IL-3 or a cocktail of cytokines. The CD14 high CD16 + cells formed a homogenous population of monocytes and macrophages that did not proliferate.
Interestingly, whatever the cytokine used and the time in culture, a CD14 high CD16cell population was not observed. In contrast, in adult blood, the CD14 high CD16monocytes represent the major blood population while the CD14 high CD16 + subset accounts for only 10% of all adult monocytes 18 . The difference in phenotype between embryonic/fetal and adult blood monocytes could reflect developmental changes in the monocyte/macrophage lineage. In order to answer this question, we compared the differentiation pattern of CD34 + cells from human fetal liver and adult blood into the monocyte/macrophage lineage using a similar cocktail of hematopoietic cytokines. This approach demonstrated that monocyte/macrophage differentiation from hESC and fetal liver was extremely close and occurred from a CD14 low CD16progenitor in contrast to adult cultures where macrophage differentiation occurred through a CD14 high CD16differentiation step. In addition, we confirmed results obtained on mouse embryonic monopoiesis that demonstrated the redundancy of M-CSF, GM-CSF and IL-3. 14, 35 In mice, a bone marrow progenitor with a M-CSFR + CXCR3 + Flt3 + phenotype, termed MDP, give rise to several monocyte/macrophage subsets and dendritic cells 4, 31 . The hESC-derived CD14 low CD16 -cells also expressed the CD115 (M-CSFR), FLT3 and CXCR3 gave rise to both dendritic cells and macrophages, and thus could be the equivalent of the MDP murine progenitor.
This assumption will require further experiments performed at the unicellular level to be confirmed.
Our findings underscore the presence of a developmental regulation in human monocyte/macrophage differentiation. Mouse embryonic macrophages are specialized in phagocytosis, tissue remodeling and angiogenesis 15, 17 . Here, we show that the CD14 + CD16 + embryonic and fetal monocytes/macrophages demonstrated a CD62L -, CCR2 -, CCR5 + , CX3CR1 + phenotype that overlapped with that of adult non-classical monocytes 3 . Additionally, they exhibited a positive ratio between anti-inflammatory and pro-inflammatory cytokines suggesting M2 polarization and responded poorly to interferon γ and LPS. Our finding that embryonic/fetal macrophages secrete higher amount of TGF-β1 suggest a possible implication of additional paracrine/autocrine mechanisms that control the polarization of immune cells contributing to the maternalfetal tolerance during embryonic development.
M2 markers identified in embryonic and fetal monocytes/macrophages include IGF1, LYVE1, MRC1, STAB1 and MMP12, which are expressed on their murine counterparts and on monocytes expressing the angiopoietin receptor Tie2 (TEMs) and human tumorassociated macrophages (TAMs) 17 . These latter cells promote tumor development by providing growth factors and remodeling factors that facilitate invasion and metastasis 14, [36] [37] . The cytokines secreted at the highest level by the embryonic subset were either those regulating the degradation of extracellular matrix, like MMPs, Serpins and TIMPs or pleiotropic cytokines, like IGFs, NRG1,TGF-b known to act at the different stages of morphogenesis in mouse embryo 14, [38] [39] . The impressive production of a wide range of metalloproteases suggests that embryonic and fetal macrophages may have specific trophic functions to regulate tissue architecture and cell migration [40] [41] ; human ES and fetal liver-derived macrophages particularly expressed a high level of MMP12, a differential marker between embryonic TEM and other embryonic macrophages 17 . In addition hESC-derived monocytes/macrophages synthesized a large pattern of factors involved in angiogenesis that could even be up regulated in a hypoxic embryonic environment. One of the characteristics of adult TEMs is to promote angiogenesis in xenograft transplant 19 . In a similar assay, we could not demonstrate a significant proangiogenic activity using our fetal liver and hES derived "TEMs". This negative result may have three explanations: -the assay used, as in our hand a profuse angiogenesis was observed in the control group, -the exit of embryonic macrophages from the tumor ortheir apoptosis after cytokine starvation. Nevertheless embryonic cells promoted the enlargement of the tumor vessels lumen, which might be related to MMP secretion [38] [39] . CCL17  MMP12  CCL13  CCL22  MMP7  IGF1  MMP2  MRC1  LYVE1  CHID1  MMP9  CCL10  MMP14  STAB1  FN1  CLEC7A  INPP5D  MSR1  CX3CR1  SPI1  PDGFB  VEGF  IL1R1  NOS2  MAFB  MARCO  SPRY2  KLF4  PTX3  CXCL9  FGF2  HOXA10  ARG1 
